Pub Date : 2023-06-01DOI: 10.1016/j.ijcchd.2023.100441
Suvasini Lakshmanan , Alessia Gimelli
Advances in diagnostics and interventional/surgical treatment of patients with congenital heart disease (CHD) over the past several decades, allows a decline in rates of all-cause mortality, with a significant reduction in proportion of infant and childhood deaths with severe forms of CHD. However, the risk of premature death in adults with complex CHD remains elevated. A growing body of evidence has recently described the impact of non-cardiovascular comorbidities such as cancers, on morbidity, health care utilizations and mortality in adult patients with CHD. Aim of this review is to provide an appraisal of the current evidence that report associations between CHD and increased cancer risk in children and adults, and provide an overview of the specific risk factors.
{"title":"Cancer risk in adult congenital heart disease","authors":"Suvasini Lakshmanan , Alessia Gimelli","doi":"10.1016/j.ijcchd.2023.100441","DOIUrl":"10.1016/j.ijcchd.2023.100441","url":null,"abstract":"<div><p>Advances in diagnostics and interventional/surgical treatment of patients with congenital heart disease (CHD) over the past several decades, allows a decline in rates of all-cause mortality, with a significant reduction in proportion of infant and childhood deaths with severe forms of CHD. However, the risk of premature death in adults with complex CHD remains elevated. A growing body of evidence has recently described the impact of non-cardiovascular comorbidities such as cancers, on morbidity, health care utilizations and mortality in adult patients with CHD. Aim of this review is to provide an appraisal of the current evidence that report associations between CHD and increased cancer risk in children and adults, and provide an overview of the specific risk factors.</p></div>","PeriodicalId":73429,"journal":{"name":"International journal of cardiology. Congenital heart disease","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49252207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-01DOI: 10.1016/j.ijcchd.2023.100451
Sebastiaan W.H. van Wijk , Maaike Wulfse , Mieke M.P. Driessen , Martijn G. Slieker , Pieter A. Doevendans , Paul H. Schoof , Gert Jan J. Sieswerda , Johannes M.P.J. Breur
Background
From 1977 onwards, patients with both simple and complex transposition of the great arteries (TGA) have been treated with the arterial switch operation (ASO) in the Wilhelmina Children's Hospital/University Medical Center Utrecht the Netherlands. In this study, we compared mortality and morbidity between two patient groups: A. operated before and B. after 1991, specifically focusing on late ventricular function and reinterventions.
Methods
A single institution retrospective cohort study was performed on patients who had an ASO for either simple or complex TGA. Data were collected from medical records. The entire patient cohort (n = 283) was divided in a group with more than 30 years of follow-up (A) and a group with less than 30 years of follow-up (B). Clinical and standardized echocardiographic follow-up was evaluated.
Results
Group A consisted of 79 patients, of whom follow-up was available in 59 patients (median follow-up 34.8 years, IQR 33.0–36.9). Group B consisted of 204 patients, of whom 195 long-term survivors (median follow-up 14.9 years, IQR 10.0–21.2). Early survival was best in group B (A: 67.8% vs. B: 96.6%, p < 0.001), whereas late mortality (in total 1.8%) was similar for both groups. Reinterventions, corrected for follow-up time, were more frequent in group A (p = 0.005). In total 65 patients (25.1%) required 105 late reinterventions including 4 late aortic valve replacements. The mode of reinterventions has shifted over time, from surgical to more catheter-based (p = 0.03). The vast majority of patients functioned in NYHA class I. In contrast to the recent cohort, who have a normal average LVEF (%), the average LVEF in the oldest cohort was in the bottom percentile of normal range.
Conclusion
The majority of patients in their fifth decade after ASO are in functional class I. Early outcome improved showing reduced mortality and need for reoperation. However, a trend towards reduced left ventricular function and late aortic valve replacements justify further research.
背景:从1977年开始,荷兰乌得勒支大学医学中心威廉敏娜儿童医院对简单和复杂的大动脉转位(TGA)患者进行了动脉转换手术(ASO)治疗。在这项研究中,我们比较了两组患者的死亡率和发病率:a组在1991年之前手术,b组在1991年之后手术,特别关注晚期心室功能和再干预。方法采用单机构回顾性队列研究,对ASO患者进行简单或复杂TGA。数据是从医疗记录中收集的。将整个患者队列(n = 283)分为随访30年以上组(a组)和随访30年以下组(B组)。评估临床和标准化超声心动图随访情况。结果A组79例患者,随访59例(中位随访34.8年,IQR 33.0 ~ 36.9)。B组204例患者,其中195例长期存活(中位随访14.9年,IQR 10.0-21.2)。B组早期生存率最高(A: 67.8% vs. B: 96.6%, p <0.001),而两组的晚期死亡率(总计1.8%)相似。经随访时间校正后,A组再干预更频繁(p = 0.005)。总共65例(25.1%)患者需要105次晚期再干预,包括4例晚期主动脉瓣置换术。随着时间的推移,再干预的模式也发生了变化,从手术到更多地以导管为基础(p = 0.03)。绝大多数患者的功能为NYHA i级。与最近的队列相比,他们的平均LVEF(%)正常,而最老队列的平均LVEF处于正常范围的底部百分位数。结论ASO术后50年的大部分患者属于功能级i,早期预后改善,死亡率降低,无需再手术。然而,左心室功能下降和晚期主动脉瓣置换术的趋势值得进一步研究。
{"title":"Fifth decennium after the arterial switch operation for transposition of the great arteries","authors":"Sebastiaan W.H. van Wijk , Maaike Wulfse , Mieke M.P. Driessen , Martijn G. Slieker , Pieter A. Doevendans , Paul H. Schoof , Gert Jan J. Sieswerda , Johannes M.P.J. Breur","doi":"10.1016/j.ijcchd.2023.100451","DOIUrl":"10.1016/j.ijcchd.2023.100451","url":null,"abstract":"<div><h3>Background</h3><p>From 1977 onwards, patients with both simple and complex transposition of the great arteries (TGA) have been treated with the arterial switch operation (ASO) in the Wilhelmina Children's Hospital/University Medical Center Utrecht the Netherlands. In this study, we compared mortality and morbidity between two patient groups: A. operated before and B. after 1991, specifically focusing on late ventricular function and reinterventions.</p></div><div><h3>Methods</h3><p>A single institution retrospective cohort study was performed on patients who had an ASO for either simple or complex TGA. Data were collected from medical records. The entire patient cohort (n = 283) was divided in a group with more than 30 years of follow-up (A) and a group with less than 30 years of follow-up (B). Clinical and standardized echocardiographic follow-up was evaluated.</p></div><div><h3>Results</h3><p>Group A consisted of 79 patients, of whom follow-up was available in 59 patients (median follow-up 34.8 years, IQR 33.0–36.9). Group B consisted of 204 patients, of whom 195 long-term survivors (median follow-up 14.9 years, IQR 10.0–21.2). Early survival was best in group B (A: 67.8% vs. B: 96.6%, p < 0.001), whereas late mortality (in total 1.8%) was similar for both groups. Reinterventions, corrected for follow-up time, were more frequent in group A (p = 0.005). In total 65 patients (25.1%) required 105 late reinterventions including 4 late aortic valve replacements. The mode of reinterventions has shifted over time, from surgical to more catheter-based (p = 0.03). The vast majority of patients functioned in NYHA class I. In contrast to the recent cohort, who have a normal average LVEF (%), the average LVEF in the oldest cohort was in the bottom percentile of normal range.</p></div><div><h3>Conclusion</h3><p>The majority of patients in their fifth decade after ASO are in functional class I. Early outcome improved showing reduced mortality and need for reoperation. However, a trend towards reduced left ventricular function and late aortic valve replacements justify further research.</p></div>","PeriodicalId":73429,"journal":{"name":"International journal of cardiology. Congenital heart disease","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47650298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-01DOI: 10.1016/j.ijcchd.2023.100444
Joelle Régine Mekoa Mbarga , Estelle Tenisch , Aicha Saleh , Mathieu Le Bloa , David Desseauve , Raymond Pfister , Giulia Domenichini , Christina Corby-Zauner , Jean-Francois Surmely , Judith Bouchardy , Etienne Pruvot , Tobias Rutz
The number of women with congenital heart disease (CHD) surviving to childbearing age is continuously growing. Although most pregnancies in this patient-population are well tolerated, there is a significant risk of potentially fatal complications. We describe a case of a previously completely asymptomatic patient who was diagnosed late during pregnancy with an inferior sinus venosus type atrial septal defect (ISV-ASD) and anomalous connection of all right pulmonary veins (PAPVC) who presented a cardiac arrest with ventricular fibrillation the day after delivery. She recovered completely and underwent subsequent surgical repair and implantation of a subcutaneous defibrillator (S-ICD).
{"title":"Postpartum cardiac arrest in a woman with an uncorrected sinus venosus type of atrial septal defect: A case report","authors":"Joelle Régine Mekoa Mbarga , Estelle Tenisch , Aicha Saleh , Mathieu Le Bloa , David Desseauve , Raymond Pfister , Giulia Domenichini , Christina Corby-Zauner , Jean-Francois Surmely , Judith Bouchardy , Etienne Pruvot , Tobias Rutz","doi":"10.1016/j.ijcchd.2023.100444","DOIUrl":"10.1016/j.ijcchd.2023.100444","url":null,"abstract":"<div><p>The number of women with congenital heart disease (CHD) surviving to childbearing age is continuously growing. Although most pregnancies in this patient-population are well tolerated, there is a significant risk of potentially fatal complications. We describe a case of a previously completely asymptomatic patient who was diagnosed late during pregnancy with an inferior sinus venosus type atrial septal defect (ISV-ASD) and anomalous connection of all right pulmonary veins (PAPVC) who presented a cardiac arrest with ventricular fibrillation the day after delivery. She recovered completely and underwent subsequent surgical repair and implantation of a subcutaneous defibrillator (S-ICD).</p></div>","PeriodicalId":73429,"journal":{"name":"International journal of cardiology. Congenital heart disease","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47814184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-01DOI: 10.1016/j.ijcchd.2023.100457
Wayne C. Zheng , Yves d’Udekem , Leeanne E. Grigg , Dominica Zentner , Rachael Cordina , David S. Celermajer , Edward Buratto , Igor E. Konstantinov , Melissa G.Y. Lee
Background
Patients with single ventricle (SV) without Fontan palliation are uncommon, and their long-term outcomes remain unclear.
Methods
Retrospective study of 35 adult patients with SV without Fontan from two tertiary centers. Primary outcome was mortality.
Results
Median age at first follow-up was 31 years (IQR: 20–40). Most common defect was double inlet left ventricle (34%), and 69% had left ventricular morphology. Patients were unoperated (46%), had systemic-to-pulmonary artery shunt (31%) or bidirectional cavopulmonary shunt (23%) as final palliation. Most common reasons for not progressing to Fontan palliation were pulmonary vascular disease (54%), patient refusal (17%), Fontan takedown (14%), and hypoplastic pulmonary arteries (11%). Baseline mean hemoglobin was 195 ± 29 g/L, mean O2 saturation 83 ± 6.9%, and 4 patients in NYHA Class III‒IV. After a mean follow-up of 10 ± 8.3 years, there were 9 deaths with heart failure being the leading cause (n = 6). Age-adjusted survival of these adult SV survivors was 73% and 53% at 40 and 50 years of age, respectively. Deceased patients more frequently had renal impairment (50% vs 0%) and QRS prolongation (75% vs 16%) at baseline (all p < 0.05). During follow-up, 40% had a new arrhythmia (atrial: n = 14, ventricular: n = 3), 34% had one or more hospitalizations for heart failure, and 17% had a stroke. A greater proportion of patients with pre-existing or new atrial/ventricular arrhythmia died compared to those without (42% vs 6%, p = 0.02).
Conclusions
Patients with SV without Fontan have high mortality and a substantial burden of cardiovascular complications, particularly arrhythmia. QRS prolongation and renal impairment were associated with mortality.
{"title":"Long-term outcomes of patients with single ventricle who do not undergo Fontan palliation","authors":"Wayne C. Zheng , Yves d’Udekem , Leeanne E. Grigg , Dominica Zentner , Rachael Cordina , David S. Celermajer , Edward Buratto , Igor E. Konstantinov , Melissa G.Y. Lee","doi":"10.1016/j.ijcchd.2023.100457","DOIUrl":"https://doi.org/10.1016/j.ijcchd.2023.100457","url":null,"abstract":"<div><h3>Background</h3><p>Patients with single ventricle (SV) without Fontan palliation are uncommon, and their long-term outcomes remain unclear.</p></div><div><h3>Methods</h3><p>Retrospective study of 35 adult patients with SV without Fontan from two tertiary centers. Primary outcome was mortality.</p></div><div><h3>Results</h3><p>Median age at first follow-up was 31 years (IQR: 20–40). Most common defect was double inlet left ventricle (34%), and 69% had left ventricular morphology. Patients were unoperated (46%), had systemic-to-pulmonary artery shunt (31%) or bidirectional cavopulmonary shunt (23%) as final palliation. Most common reasons for not progressing to Fontan palliation were pulmonary vascular disease (54%), patient refusal (17%), Fontan takedown (14%), and hypoplastic pulmonary arteries (11%). Baseline mean hemoglobin was 195 ± 29 g/L, mean O<sub>2</sub> saturation 83 ± 6.9%, and 4 patients in NYHA Class III‒IV. After a mean follow-up of 10 ± 8.3 years, there were 9 deaths with heart failure being the leading cause (n = 6). Age-adjusted survival of these adult SV survivors was 73% and 53% at 40 and 50 years of age, respectively. Deceased patients more frequently had renal impairment (50% vs 0%) and QRS prolongation (75% vs 16%) at baseline (all p < 0.05). During follow-up, 40% had a new arrhythmia (atrial: n = 14, ventricular: n = 3), 34% had one or more hospitalizations for heart failure, and 17% had a stroke. A greater proportion of patients with pre-existing or new atrial/ventricular arrhythmia died compared to those without (42% vs 6%, p = 0.02).</p></div><div><h3>Conclusions</h3><p>Patients with SV without Fontan have high mortality and a substantial burden of cardiovascular complications, particularly arrhythmia. QRS prolongation and renal impairment were associated with mortality.</p></div>","PeriodicalId":73429,"journal":{"name":"International journal of cardiology. Congenital heart disease","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49774923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-01DOI: 10.1016/j.ijcchd.2023.100453
Katja Prokšelj
Despite striking improvement in survival of patients with congenital heart disease (CHD), the risk of long-term complications remains high. Stroke and systemic embolism are common and potentially devastating complications that significantly affect morbidity and mortality in CHD. The risk of stroke in adult congenital heart disease (ACHD) is higher than in the general population, patients are affected at an earlier age, and the risk continues to increase with age. Specific types of defects are at high-risk for stroke and other systemic embolisms, particularly patients with complex congenital heart disease, cyanotic heart disease, Fontan circulation, and cardiac shunts. Associated factors such as atrial arrhythmias, heart failure, mechanical valves and intracardiac devices, and infective endocarditis increase the risk of thromboembolic events. Acquired conventional risk factors for cardiovascular disease further increase the burden of stroke in the aging ACHD population. Anticoagulation is a cornerstone for prevention of thromboembolic events. Risk stratification in ACHD remains challenging and should be individualized. General risk stratification models, such as the CHA2DS2-VASc score, are not reliable in the heterogeneous ACHD population and should only be used in mild to moderate CHD. Anticoagulation is recommended as primary prevention in high-risk patients (patients with intracardiac repair, cyanotic CHD, Fontan circulation, or systemic right ventricle) with atrial arrhythmias. In patients with other CHD, general stratification models should be used to decide when to initiate anticoagulation, taking into account specificities of underlying heart disease and potential residua. Screening and treatment of conventional risk factors for cardiovascular disease may further improve long-term outcomes.
{"title":"Stroke and systemic embolism in adult congenital heart disease","authors":"Katja Prokšelj","doi":"10.1016/j.ijcchd.2023.100453","DOIUrl":"https://doi.org/10.1016/j.ijcchd.2023.100453","url":null,"abstract":"<div><p>Despite striking improvement in survival of patients with congenital heart disease (CHD), the risk of long-term complications remains high. Stroke and systemic embolism are common and potentially devastating complications that significantly affect morbidity and mortality in CHD. The risk of stroke in adult congenital heart disease (ACHD) is higher than in the general population, patients are affected at an earlier age, and the risk continues to increase with age. Specific types of defects are at high-risk for stroke and other systemic embolisms, particularly patients with complex congenital heart disease, cyanotic heart disease, Fontan circulation, and cardiac shunts. Associated factors such as atrial arrhythmias, heart failure, mechanical valves and intracardiac devices, and infective endocarditis increase the risk of thromboembolic events. Acquired conventional risk factors for cardiovascular disease further increase the burden of stroke in the aging ACHD population. Anticoagulation is a cornerstone for prevention of thromboembolic events. Risk stratification in ACHD remains challenging and should be individualized. General risk stratification models, such as the CHA<sub>2</sub>DS<sub>2</sub>-VASc score, are not reliable in the heterogeneous ACHD population and should only be used in mild to moderate CHD. Anticoagulation is recommended as primary prevention in high-risk patients (patients with intracardiac repair, cyanotic CHD, Fontan circulation, or systemic right ventricle) with atrial arrhythmias. In patients with other CHD, general stratification models should be used to decide when to initiate anticoagulation, taking into account specificities of underlying heart disease and potential residua. Screening and treatment of conventional risk factors for cardiovascular disease may further improve long-term outcomes.</p></div>","PeriodicalId":73429,"journal":{"name":"International journal of cardiology. Congenital heart disease","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49774934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-01DOI: 10.1016/j.ijcchd.2023.100450
Magdi H. Yacoub , Ahmed Afifi , Hatem Hosny , Ahmed Mahgoub , Mohamed Nagy , Amr El Sawy , Nairouz Shehata , Ayman M. Ibrahim , Mina Azer , Abdelrahman Elafifi , Soha Romeih
Background
Nikaidoh translocation operation is increasingly being used for patients with TGA, VSD and LVOTO. The early results of this operation are excellent and possibly better than the Rastelli repair. However, the long-term results remain inadequately defined.
Methods and results
Detailed follow up data of a patient, 12 years after Nikaidoh operation, using computerized image analysis are reported. The patient complained of chest pain on exertion. Imaging showed severe dilatation of the non-coronary sinus of the aortic root, compressing the RVOT and pulmonary artery branches resulting in RV dilatation. The dilated aortic sinus showed marked pulsatility with expansion during systole and diastole. As the child was symptomatic, with a risk of aneurysm rupture, excision was performed. This complication is thought to be due to interruption of the innervation of the root as well as cutting vasa vasorum.
Conclusion
Nikaidoh operation is a viable solution for the repair of TGA, VSD, PS. Dilatation of the neo-aortic root should be carefully followed and causes of the dilatation investigated.
{"title":"Structure and function of the aortic and pulmonary outflows in a patient, 12 years after Nikaidoh operation, A cautionary Note","authors":"Magdi H. Yacoub , Ahmed Afifi , Hatem Hosny , Ahmed Mahgoub , Mohamed Nagy , Amr El Sawy , Nairouz Shehata , Ayman M. Ibrahim , Mina Azer , Abdelrahman Elafifi , Soha Romeih","doi":"10.1016/j.ijcchd.2023.100450","DOIUrl":"10.1016/j.ijcchd.2023.100450","url":null,"abstract":"<div><h3>Background</h3><p>Nikaidoh translocation operation is increasingly being used for patients with TGA, VSD and LVOTO. The early results of this operation are excellent and possibly better than the Rastelli repair. However, the long-term results remain inadequately defined.</p></div><div><h3>Methods and results</h3><p>Detailed follow up data of a patient, 12 years after Nikaidoh operation, using computerized image analysis are reported. The patient complained of chest pain on exertion. Imaging showed severe dilatation of the non-coronary sinus of the aortic root, compressing the RVOT and pulmonary artery branches resulting in RV dilatation. The dilated aortic sinus showed marked pulsatility with expansion during systole and diastole. As the child was symptomatic, with a risk of aneurysm rupture, excision was performed. This complication is thought to be due to interruption of the innervation of the root as well as cutting vasa vasorum.</p></div><div><h3>Conclusion</h3><p>Nikaidoh operation is a viable solution for the repair of TGA, VSD, PS. Dilatation of the neo-aortic root should be carefully followed and causes of the dilatation investigated.</p></div>","PeriodicalId":73429,"journal":{"name":"International journal of cardiology. Congenital heart disease","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47190266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-01DOI: 10.1016/j.ijcchd.2023.100459
Daan Bosshardt , Michiel Voskuil , Gregor J. Krings , Mirella M.C. Molenschot , Maarten J. Suttorp , Heleen B. van der Zwaan , Martijn C. Post
Background
In order to prevent right ventricular (RV) dysfunction, closure of secundum type atrial septal defects (ASD) is often indicated and percutaneous closure is the preferred treatment modality to do so. The magnitude and time course of RV remodeling is still incompletely understood.
Methods
This retrospective cohort study included consecutive patients who underwent percutaneous secundum ASD closure in two tertiary referral centers in The Netherlands. Main study parameters were RV and right atrial dimensions measured with transthoracic echocardiography before and after percutaneous ASD closure. Secondary outcome was change in New York Heart Association (NYHA) functional class at follow-up.
Results
From the 454 patients who underwent secundum ASD closure, 88 patients (median age 46 [range 17–84]) were included. The majority of RV and right atrial dimensional improvement occurred within 24 h. After a median follow-up of 569 days (IQR: 280–772) a further decrease in dimensions was observed. Comparing baseline and latest follow-up, end-diastolic RV basal diameter decreased from 4.5 SEM 0.1 to 3.9 SEM 0.1 cm (p < 0.001) and end-systolic right atrial area from 22.9 SEM 1.0 to 17.9 SEM 0.7 cm2 (p < 0.001). No significant changes in RV function were observed. NYHA functional class improved from 1.5 at baseline (IQR: 1.0–2.0) to 1.0 (IQR: 1.0–1.5) at latest follow-up (p < 0.001).
Conclusion
Remodeling of the RV heart dimensions commences within 24 h after percutaneous secundum ASD closure for the majority of patients, followed by a further gradual recovery. A concurrent improvement of NYHA functional class was observed during follow-up.
背景:为了防止右心室功能障碍,经常需要对二次型房间隔缺损(ASD)进行闭合术,经皮闭合术是首选的治疗方式。右心室重构的大小和时间进程仍不完全清楚。方法:本回顾性队列研究包括荷兰两家三级转诊中心接受经皮二次ASD闭合术的连续患者。主要研究参数为经皮ASD闭合前后经胸超声心动图测量的右房和右房尺寸。次要终点是随访时纽约心脏协会(NYHA)功能分级的变化。结果454例接受二次ASD闭合的患者中,88例患者(中位年龄46岁[范围17-84])入选。大多数右房和右房房度改善发生在24小时内。中位随访569天(IQR: 280-772)后,观察到尺寸进一步下降。与基线和最新随访相比,舒张末期右心室基底直径从4.5 SEM 0.1下降到3.9 SEM 0.1 cm (p <0.001),收缩期末右心房面积从22.9 SEM 1.0增加到17.9 SEM 0.7 cm2 (p <0.001)。右心室功能未见明显变化。NYHA功能分级从基线时的1.5 (IQR: 1.0 - 2.0)改善到最新随访时的1.0 (IQR: 1.0 - 1.5) (p <0.001)。结论大多数患者在经皮二次ASD闭合后24小时内开始右心室尺寸重塑,随后逐渐恢复。随访期间观察到NYHA功能分级同时改善。
{"title":"Echocardiographic right ventricular remodeling after percutaneous atrial septal defect closure","authors":"Daan Bosshardt , Michiel Voskuil , Gregor J. Krings , Mirella M.C. Molenschot , Maarten J. Suttorp , Heleen B. van der Zwaan , Martijn C. Post","doi":"10.1016/j.ijcchd.2023.100459","DOIUrl":"10.1016/j.ijcchd.2023.100459","url":null,"abstract":"<div><h3>Background</h3><p>In order to prevent right ventricular (RV) dysfunction, closure of secundum type atrial septal defects (ASD) is often indicated and percutaneous closure is the preferred treatment modality to do so. The magnitude and time course of RV remodeling is still incompletely understood.</p></div><div><h3>Methods</h3><p>This retrospective cohort study included consecutive patients who underwent percutaneous secundum ASD closure in two tertiary referral centers in The Netherlands. Main study parameters were RV and right atrial dimensions measured with transthoracic echocardiography before and after percutaneous ASD closure. Secondary outcome was change in New York Heart Association (NYHA) functional class at follow-up.</p></div><div><h3>Results</h3><p>From the 454 patients who underwent secundum ASD closure, 88 patients (median age 46 [range 17–84]) were included. The majority of RV and right atrial dimensional improvement occurred within 24 h. After a median follow-up of 569 days (IQR: 280–772) a further decrease in dimensions was observed. Comparing baseline and latest follow-up, end-diastolic RV basal diameter decreased from 4.5 SEM 0.1 to 3.9 SEM 0.1 cm (<em>p</em> < <em>0.001)</em> and end-systolic right atrial area from 22.9 SEM 1.0 to 17.9 SEM 0.7 cm<sup>2</sup> (<em>p</em> < <em>0.001)</em>. No significant changes in RV function were observed. NYHA functional class improved from 1.5 at baseline (IQR: 1.0–2.0) to 1.0 (IQR: 1.0–1.5) at latest follow-up (<em>p</em> < <em>0.001)</em>.</p></div><div><h3>Conclusion</h3><p>Remodeling of the RV heart dimensions commences within 24 h after percutaneous secundum ASD closure for the majority of patients, followed by a further gradual recovery. A concurrent improvement of NYHA functional class was observed during follow-up.</p></div>","PeriodicalId":73429,"journal":{"name":"International journal of cardiology. Congenital heart disease","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45183355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-01DOI: 10.1016/j.ijcchd.2023.100454
Becky Yi-Wen Liao , Anthony Kueh , Andrew Martin , Jignesh Shah , Ajay Iyengar , Chethan Kasargod
Right ventricular outflow tract ventricular tachycardia (RVOT VT) is a well-recognised subtype of idiopathic ventricular tachyarrhythmia and often described in young healthy individuals. This arrhythmia typically occurs in patients with a structurally normal heart, and in this context is generally considered benign. In this case we present a rare association between RVOT VT and a ruptured sinus of Valsalva aneurysm in a patient known to have a restrictive ventricular septal defect. Prompt surgical intervention was necessary to prevent potentially life threatening consequences.
The diagnostic and surgical evaluation learnt from this case would be useful to remind clinicians to explore rarer causes of RVOT VT especially when patients have underlying congenital heart disease. This case also highlights the importance of utilizing multi-modality imaging for the anatomical assessment of this pathology, which aids definitive management.
{"title":"Not so benign- A rare cause of right ventricular outflow tract ventricular tachycardia in patient with congenital heart disease","authors":"Becky Yi-Wen Liao , Anthony Kueh , Andrew Martin , Jignesh Shah , Ajay Iyengar , Chethan Kasargod","doi":"10.1016/j.ijcchd.2023.100454","DOIUrl":"10.1016/j.ijcchd.2023.100454","url":null,"abstract":"<div><p>Right ventricular outflow tract ventricular tachycardia (RVOT VT) is a well-recognised subtype of idiopathic ventricular tachyarrhythmia and often described in young healthy individuals. This arrhythmia typically occurs in patients with a structurally normal heart, and in this context is generally considered benign. In this case we present a rare association between RVOT VT and a ruptured sinus of Valsalva aneurysm in a patient known to have a restrictive ventricular septal defect. Prompt surgical intervention was necessary to prevent potentially life threatening consequences.</p><p>The diagnostic and surgical evaluation learnt from this case would be useful to remind clinicians to explore rarer causes of RVOT VT especially when patients have underlying congenital heart disease. This case also highlights the importance of utilizing multi-modality imaging for the anatomical assessment of this pathology, which aids definitive management.</p></div>","PeriodicalId":73429,"journal":{"name":"International journal of cardiology. Congenital heart disease","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42335129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-01DOI: 10.1016/j.ijcchd.2023.100452
Mathies Daene , Lore De Pauw , Pieter De Meester , Els Troost , Philip Moons , Marc Gewillig , Filip Rega , Alexander Van De Bruaene , Werner Budts
Background and aims
Patients with Down Syndrome (DS) are frequently born with an atrioventricular septal defect (AVSD). Surgical repair of the defect aims to minimize mortality and morbidity. However, a surgical intervention, specifically in DS patients, is not without risk and a subgroup of patients underwent only conservative non-surgical treatment. Outcome data of these different approaches are scarce. The aim of this retrospective study was to compare the long-term outcome of DS patients with and without surgery for AVSD.
Methods
DS patients registered with AVSD in the hospital's database from January 1980 till December 2020 were selected. Patient characteristics, peri-operative if appropriate, and follow-up data were obtained from the medical files.
Results
In total, 72 unrepaired (36 male, 50%) and 134 repaired patients (61 male, 46%) were included. After a maximum of 60 years of follow-up, the all-cause mortality was 45.8% and 17.1%, respectively. Thirty-six percent and 13%, respectively, were labeled as non-cardiovascular death. Mean survival time for unrepaired AVSD was 40.7 years (95% CI 36.1–45.2) and for repaired AVSD 38.5 years (95% CI 35.3–41.6) (Log rank p = 0.465). However, the survival rate 35 years after birth was 62.1% for unrepaired patients versus 81.7% for repaired patients. Mortality rates were the highest the first months after surgical repair.
Conclusions
The mean survival rate of Down patients, born with an AVSD, did not differ between repair or not. However, long-term survival rate was higher in patients who underwent surgical repair. Mortality was highest the first months after surgery.
背景和目的唐氏综合征(DS)患者通常出生时伴有房室间隔缺损(AVSD)。手术修复缺损的目的是减少死亡率和发病率。然而,手术干预,特别是在退行性椎体滑移患者中,并非没有风险,有一亚组患者仅接受保守的非手术治疗。这些不同方法的结果数据很少。本回顾性研究的目的是比较行和不行AVSD手术的退行性椎体滑移患者的长期预后。方法选择1980年1月至2020年12月在本院数据库登记的AVSD患者。从医疗档案中获得患者特征、围手术期(如果合适)和随访数据。结果未修复72例(男性36例,占50%),修复134例(男性61例,占46%)。经过最长60年的随访,全因死亡率分别为45.8%和17.1%。分别有36%和13%的人被标记为非心血管死亡。未修复AVSD的平均生存时间为40.7年(95% CI 36.1-45.2),修复AVSD的平均生存时间为38.5年(95% CI 35.3-41.6) (Log rank p = 0.465)。然而,未修复患者出生后35年的生存率为62.1%,而修复患者为81.7%。手术修复后的头几个月死亡率最高。结论先天性AVSD的唐氏患者的平均生存率与是否修复无显著差异。然而,接受手术修复的患者的长期存活率更高。术后的头几个月死亡率最高。
{"title":"Outcome of Down patients with repaired versus unrepaired atrioventricular septal defect","authors":"Mathies Daene , Lore De Pauw , Pieter De Meester , Els Troost , Philip Moons , Marc Gewillig , Filip Rega , Alexander Van De Bruaene , Werner Budts","doi":"10.1016/j.ijcchd.2023.100452","DOIUrl":"10.1016/j.ijcchd.2023.100452","url":null,"abstract":"<div><h3>Background and aims</h3><p>Patients with Down Syndrome (DS) are frequently born with an atrioventricular septal defect (AVSD). Surgical repair of the defect aims to minimize mortality and morbidity. However, a surgical intervention, specifically in DS patients, is not without risk and a subgroup of patients underwent only conservative non-surgical treatment. Outcome data of these different approaches are scarce. The aim of this retrospective study was to compare the long-term outcome of DS patients with and without surgery for AVSD.</p></div><div><h3>Methods</h3><p>DS patients registered with AVSD in the hospital's database from January 1980 till December 2020 were selected. Patient characteristics, peri-operative if appropriate, and follow-up data were obtained from the medical files.</p></div><div><h3>Results</h3><p>In total, 72 unrepaired (36 male, 50%) and 134 repaired patients (61 male, 46%) were included. After a maximum of 60 years of follow-up, the all-cause mortality was 45.8% and 17.1%, respectively. Thirty-six percent and 13%, respectively, were labeled as non-cardiovascular death. Mean survival time for unrepaired AVSD was 40.7 years (95% CI 36.1–45.2) and for repaired AVSD 38.5 years (95% CI 35.3–41.6) (Log rank p = 0.465). However, the survival rate 35 years after birth was 62.1% for unrepaired patients versus 81.7% for repaired patients. Mortality rates were the highest the first months after surgical repair.</p></div><div><h3>Conclusions</h3><p>The mean survival rate of Down patients, born with an AVSD, did not differ between repair or not. However, long-term survival rate was higher in patients who underwent surgical repair. Mortality was highest the first months after surgery.</p></div>","PeriodicalId":73429,"journal":{"name":"International journal of cardiology. Congenital heart disease","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49414544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-01DOI: 10.1016/j.ijcchd.2023.100447
Jill M. Steiner , Erin Abu-Rish Blakeney , Andrea Corage Baden , Vea Freeman , Joyce Yi-Frazier , J. Randall Curtis , Ruth A. Engelberg , Abby R. Rosenberg
Background
Adult congenital heart disease (ACHD) is a lifelong illness that presents ongoing challenges to quality of life. Fostering personal resilience resources to sustain well-being can enhance patients’ psychosocial health.
Objective
We aimed to describe patients’ resilience experiences: how they understand, develop, and utilize resilience resources in managing ACHD.
Methods
We conducted a qualitative study of patients with ACHD. Participants were recruited using maximum variation sampling. Individual, semi-structured interviews were conducted June 2020 to August 2021. We queried approaches to managing ACHD-related stress and experiences with resilience and analyzed responses with thematic analysis.
Results
Participant (N = 25) median age was 32 years (range 22–44); 52% identified as female and 72% non-Hispanic white. Participants’ anatomic ACHD was moderate (56%) or complex (44%); physiologically, 76% were functional class C or D. Participants described various resilience resources, which map to an established resilience framework: 1) internal resources: maintaining positivity, self-directed activity, and setting goals; 2) external resources: social support; 3) existential resources: purpose, gratitude, and cultivating health. Even among participants who reported feeling unfamiliar (8/25) with the term “resilience,” all participants shared experiences reflecting resilience developed while living with ACHD.
Conclusion
ACHD-relevant resilience resources may help patients and clinicians navigate ACHD-related stress and promote psychosocial well-being.
{"title":"Definitions of resilience and resilience resource use as described by adults with congenital heart disease","authors":"Jill M. Steiner , Erin Abu-Rish Blakeney , Andrea Corage Baden , Vea Freeman , Joyce Yi-Frazier , J. Randall Curtis , Ruth A. Engelberg , Abby R. Rosenberg","doi":"10.1016/j.ijcchd.2023.100447","DOIUrl":"10.1016/j.ijcchd.2023.100447","url":null,"abstract":"<div><h3>Background</h3><p>Adult congenital heart disease (ACHD) is a lifelong illness that presents ongoing challenges to quality of life. Fostering personal resilience resources to sustain well-being can enhance patients’ psychosocial health.</p></div><div><h3>Objective</h3><p>We aimed to describe patients’ resilience experiences: how they understand, develop, and utilize resilience resources in managing ACHD.</p></div><div><h3>Methods</h3><p>We conducted a qualitative study of patients with ACHD. Participants were recruited using maximum variation sampling. Individual, semi-structured interviews were conducted June 2020 to August 2021. We queried approaches to managing ACHD-related stress and experiences with resilience and analyzed responses with thematic analysis.</p></div><div><h3>Results</h3><p>Participant (N = 25) median age was 32 years (range 22–44); 52% identified as female and 72% non-Hispanic white. Participants’ anatomic ACHD was moderate (56%) or complex (44%); physiologically, 76% were functional class C or D. Participants described various resilience resources, which map to an established resilience framework: 1) internal resources: maintaining positivity, self-directed activity, and setting goals; 2) external resources: social support; 3) existential resources: purpose, gratitude, and cultivating health. Even among participants who reported feeling unfamiliar (8/25) with the term “resilience,” all participants shared experiences reflecting resilience developed while living with ACHD.</p></div><div><h3>Conclusion</h3><p>ACHD-relevant resilience resources may help patients and clinicians navigate ACHD-related stress and promote psychosocial well-being.</p></div>","PeriodicalId":73429,"journal":{"name":"International journal of cardiology. Congenital heart disease","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ac/86/nihms-1904680.PMC10486316.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10293968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}